Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1984 Nov;18(5):685–692. doi: 10.1111/j.1365-2125.1984.tb02530.x

Estimation of gentamicin clearance and volume of distribution in neonates and young children.

A W Kelman, A H Thomson, B Whiting, S M Bryson, D A Steedman, G E Mawer, L A Samba-Donga
PMCID: PMC1463552  PMID: 6508978

Abstract

Gentamicin therapy should be guided by serum level monitoring in all age groups, dosage adjustments depending on age related changes in pharmacokinetics. Population data analysed from two centres (43 infants from Glasgow and 100 infants and children from Manchester) by the computer program NONMEM showed that volume of distribution was related to body weight by a proportionality factor that decreased from the region of 0.41-0.46 l/kg in children less than 3 months to 0.25-0.32 l/kg in older children, a value which merges with that accepted for adults (0.25 l/kg). In both young and older children, clearance was also found to be dependent on body weight. Renal function (creatinine concentrations) provided no further explanatory power. When these results were used prospectively to forecast gentamicin concentrations with a Bayesian kinetic parameter estimation program, trough concentrations were more precisely predicted than peaks when a single concentration measurement was used. In clinical practice, however, two concentration measurements are usually routinely available and these should lead to greater precision of both peak and trough predictions. These results have been incorporated into a simple nomogram which can be used to determine a dose of gentamicin which will achieve target peak concentrations in infants, assuming that troughs should not exceed 2 micrograms/ml.

Full text

PDF
685

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashurst A., Houston I. B., Mawer G. E., Sambo-Donga L. Factors influencing the therapeutic response to gentamicin treatment in children [proceedings]. Br J Clin Pharmacol. 1977 Jun;4(3):394P–395P. doi: 10.1111/j.1365-2125.1977.tb00742.x. [DOI] [PubMed] [Google Scholar]
  2. Assael B. M., Gianni V., Marini A., Peneff P., Sereni F. Gentamicin dosage in preterm and term neonates. Arch Dis Child. 1977 Nov;52(11):883–886. doi: 10.1136/adc.52.11.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bendush C. L., Weber R. Tobramycin sulfate: a summary of worldwide experience from clinical trials. J Infect Dis. 1976 Aug;134 (Suppl):S219–S234. doi: 10.1093/infdis/134.supplement_1.s219. [DOI] [PubMed] [Google Scholar]
  4. Haughey D. B., Hilligoss D. M., Grassi A., Schentag J. J. Two-compartment gentamicin pharmacokinetics in premature neonates: a comparison to adults with decreased glomerular filtration rates. J Pediatr. 1980 Feb;96(2):325–330. doi: 10.1016/s0022-3476(80)80840-7. [DOI] [PubMed] [Google Scholar]
  5. Hewitt W. L. Gentamicin: toxicity in perspective. Postgrad Med J. 1974 Nov;50 (Suppl 7):55–61. [PubMed] [Google Scholar]
  6. Hindmarsh K. W., Nation R. L., Williams G. L., John E., French J. N. Pharmacokinetics of gentamicin in very low birth weight preterm infants. Eur J Clin Pharmacol. 1983;24(5):649–653. doi: 10.1007/BF00542216. [DOI] [PubMed] [Google Scholar]
  7. Kelman A. W., Whiting B., Bryson S. M. OPT: a package of computer programs for parameter optimisation in clinical pharmacokinetics. Br J Clin Pharmacol. 1982 Aug;14(2):247–256. doi: 10.1111/j.1365-2125.1982.tb01969.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. McCracken G. H., Jr, Jones L. G. Gentamicin in the neonatal period. Am J Dis Child. 1970 Dec;120(6):524–533. doi: 10.1001/archpedi.1970.02100110072007. [DOI] [PubMed] [Google Scholar]
  9. Sheiner L. B., Halkin H., Peck C., Rosenberg B., Melmon K. L. Improved computer-assisted digoxin therapy. A method using feedback of measured serum digoxin concentrations. Ann Intern Med. 1975 May;82(5):619–627. doi: 10.7326/0003-4819-82-5-619. [DOI] [PubMed] [Google Scholar]
  10. Sheiner L. B., Rosenberg B., Marathe V. V. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm. 1977 Oct;5(5):445–479. doi: 10.1007/BF01061728. [DOI] [PubMed] [Google Scholar]
  11. Szefler S. J., Wynn R. J., Clarke D. F., Buckwald S., Shen D., Schentag J. J. Relationship of gentamicin serum concentrations to gestational age in preterm and term neonates. J Pediatr. 1980 Aug;97(2):312–315. doi: 10.1016/s0022-3476(80)80506-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES